BioAge Labs, Inc. (BIOA)
NasdaqGS • Currently up 0.09 (+0.95%) in today's trading session
1 member of Congress has disclosed 1 trade in BioAge Labs, Inc. (BIOA) via STOCK Act filings. The most recent disclosure was a sale by Suzan K. DelBene on 9 June 2016. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
BioAge Labs, Inc. is currently trading at $9.59, positioned at 23% of its 52-week range ($4.68 – $25.95).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
BioAge Labs, Inc. Price History and Technical Analysis
Congressional Trading Activity for BIOA
| Suzan K. DelBene | 9 Jun 2016 | 13 Jul 2016 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about BIOA
- Which members of Congress have traded BIOA?
- 1 member of Congress has disclosed 1 trade in BioAge Labs, Inc. (BIOA) under the STOCK Act: Suzan K. DelBene.
- When was BIOA most recently disclosed by Congress?
- The most recent BIOA disclosure was a sale by Suzan K. DelBene on 9 June 2016.
- What is the total disclosed congressional trading volume for BIOA?
- Members of Congress have disclosed approximately $8K in BIOA sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in BIOA?
- This BIOA page updates as soon as new STOCK Act disclosures are filed for BioAge Labs, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track BIOA in Congress
See when politicians buy or sell this stock